Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Rieckmann P

Collect these papers and discover other ones on Labmeeting. Learn more.

Impact of multiple sclerosis relapses on progression diminishes with time.

+ cite this

+ View Abstract

Tremlett H, Yousefi M, Devonshire V, Rieckmann P, Zhao Y, and UBC Neurologists

Neurology 73(20):1616-23, 2009 Nov 17 - Who cited this? | PubMed ID: 19890070 | Fulltext

Symptomatology of MS: results from the German MS Registry.

+ cite this

+ View Abstract

Stuke K, Flachenecker P, Zettl UK, Elias WG, Freidel M, Haas J, Pitschnau-Michel D, Schimrigk S, and Rieckmann P

Journal of neurology 256(11):1932-5, 2009 Nov - Who cited this? | PubMed ID: 19629565 | Fulltext

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial.

+ cite this

+ View Abstract

Comi G, Martinelli V, Rodegher M, Moiola L, Bajenaru O, Carra A, Elovaara I, Fazekas F, Hartung HP, Hillert J, King J, Komoly S, Lubetzki C, Montalban X, Myhr KM, Ravnborg M,

(show remaining authors)

Lancet 374(9700):1503-11, 2009 Oct 31 - Who cited this? | PubMed ID: 19815268 | Fulltext

Concepts of induction and escalation therapy in multiple sclerosis.

+ cite this

+ View Abstract

Rieckmann P

Journal of the neurological sciences 277 Suppl 1:S42-5, 2009 Feb 1 - Who cited this? | PubMed ID: 19200866 | Fulltext

Clinical trials in multiple sclerosis: current and future requirements - potential pitfalls.

+ cite this

+ View Abstract

Rieckmann P

Journal of neurology 255 Suppl 6:66-8, 2008 Dec - Who cited this? | PubMed ID: 19300962 | Fulltext

[Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis.].

+ cite this

+ View Abstract

Sailer M, Fazekas F, Gass A, Kappos L, Radue EW, Rieckmann P, Toyka K, Wiendl H, and Bendszus M

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 180(11):994-1001, 2008 Nov - Who cited this? | PubMed ID: 18937154 | Fulltext

Cognitive fMRI and soluble telencephalin assessment in patients with localization-related epilepsy.

+ cite this

+ View Abstract

Jansen JF, Vlooswijk MC, de Baets MH, de Krom MC, Rieckmann P, Backes WH, Aldenkamp AP, and SEGAED Study Group

Acta neurologica Scandinavica 118(4):232-9, 2008 Oct - Who cited this? | PubMed ID: 18460045 | Fulltext

Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations.

+ cite this

+ View Abstract

Multiple Sclerosis Therapy Consensus Group (MSTCG), Wiendl H, Toyka KV, Rieckmann P, Gold R, Hartung HP, and Hohlfeld R

Journal of neurology 255(10):1449-63, 2008 Oct - Who cited this? | PubMed ID: 19005625 | Fulltext

Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.

+ cite this

+ View Abstract

Fazekas F, Lublin FD, Li D, Freedman MS, Hartung HP, Rieckmann P, Sørensen PS, Maas-Enriquez M, Sommerauer B, Hanna K, , and

Neurology 71(4):265, 2008 Jul 22 - Who cited this? | PubMed ID: 18645164 | Fulltext

Imatinib buys time for brain after stroke.

+ cite this

Rieckmann P

Nature medicine 14(7):712-3, 2008 Jul - Who cited this? | PubMed ID: 18607366 | Fulltext

Common Cellular and Diverse Genetic Basis of Thymoma-associated Myasthenia Gravis: Role of MHC Class II and AIRE Genes and Genetic Polymorphisms.

+ cite this

+ View Abstract

Ströbel P, Chuang WY, Chuvpilo S, Zettl A, Katzenberger T, Kalbacher H, Rieckmann P, Nix W, Schalke B, Gold R, Müller-Hermelink HK, Peterson P, and Marx A

Annals of the New York Academy of Sciences 1132:143, 2008 Jun - Who cited this? | PubMed ID: 18567864 | Fulltext

Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis.

+ cite this

+ View Abstract

Ruprecht K, Gronen F, Sauter M, Best B, Rieckmann P, and Mueller-Lantzsch N

Journal of neurovirology 14(2):143, 2008 Apr - Who cited this? | PubMed ID: 18444086 | Fulltext

Triggering receptor expressed on myeloid cells-1 (TREM-1) expression on gastric epithelium: implication for a role of TREM-1 in Helicobacter pylori infection.

+ cite this

+ View Abstract

Schmausser B, Endrich S, Beier D, Moran AP, Burek CJ, Rosenwald A, Rieckmann P, Müller-Hermelink HK, and Eck M

Clinical and experimental immunology 152(1):88-94, 2008 Apr - Who cited this? | PubMed ID: 18321350 | Fulltext

IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations.

+ cite this

+ View Abstract

Weber F, Fontaine B, Cournu-Rebeix I, Kroner A, Knop M, Lutz S, Müller-Sarnowski F, Uhr M, Bettecken T, Kohli M, Ripke S, Ising M, Rieckmann P, Brassat D, Semana G, Babron MC,

(show remaining authors)

Genes and immunity 9(3):259-63, 2008 Apr - Who cited this? | PubMed ID: 18354419 | Fulltext

Treating multiple sclerosis with monoclonal antibodies.

+ cite this

+ View Abstract

Buttmann M and Rieckmann P

Expert review of neurotherapeutics 8(3):433-55, 2008 Mar - Who cited this? | PubMed ID: 18345973 | Fulltext

Multiple sclerosis registry in Germany: results of the extension phase 2005/2006.

+ cite this

+ View Abstract

Flachenecker P, Stuke K, Elias W, Freidel M, Haas J, Pitschnau-Michel D, Schimrigk S, Zettl UK, and Rieckmann P

Deutsches Arzteblatt international 105(7):113-9, 2008 Feb - Who cited this? | PubMed ID: 19633761 | Fulltext

mtDNA nt13708A variant increases the risk of multiple sclerosis.

+ cite this

+ View Abstract

Yu X, Koczan D, Sulonen AM, Akkad DA, Kroner A, Comabella M, Costa G, Corongiu D, Goertsches R, Camina-Tato M, Thiesen HJ, Nyland HI, Mørk SJ, Montalban X, Rieckmann P, Marrosu MG,

(show remaining authors)

PLoS ONE 3(2), 2008 - Who cited this? | PubMed ID: 18270557 | Fulltext

Orthostatic tremor in three brothers.

+ cite this

Fischer M, Kress W, Reiners K, and Rieckmann P

Journal of neurology 254(12):1759-60, 2007 Dec - Who cited this? | PubMed ID: 17657402 | Fulltext

Emerging oral therapies for multiple sclerosis.

+ cite this

+ View Abstract

Cohen BA and Rieckmann P

International journal of clinical practice 61(11):1922-30, 2007 Nov - Who cited this? | PubMed ID: 17784852 | Fulltext

TRAIL, CXCL10 and CCL2 plasma levels during long-term Interferon-beta treatment of patients with multiple sclerosis correlate with flu-like adverse effects but do not predict therapeutic response.

+ cite this

+ View Abstract

Buttmann M, Merzyn C, Hofstetter HH, and Rieckmann P

Journal of neuroimmunology 190(1-2):170-6, 2007 Oct - Who cited this? | PubMed ID: 17884184 | Fulltext

[Recent advances in the pathogenesis and immunotherapy of multiple sclerosis].

+ cite this

+ View Abstract

Gold R and Rieckmann P

Der Nervenarzt 78 Suppl 1:15-24; quiz 25, 2007 Sep - Who cited this? | PubMed ID: 17668159 | Fulltext

Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration.

+ cite this

+ View Abstract

Buttmann M, Lorenz A, Weishaupt A, and Rieckmann P

Journal of neurochemistry 102(4):1001, 2007 Aug - Who cited this? | PubMed ID: 17442054 | Fulltext

Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1).

+ cite this

+ View Abstract

Ströbel P, Murumägi A, Klein R, Luster M, Lahti M, Krohn K, Schalke B, Nix W, Gold R, Rieckmann P, Toyka K, Burek C, Rosenwald A, Müller-Hermelink HK, Pujoll-Borrell R, Meager A,

(show remaining authors)

The Journal of pathology 211(5):563-71, 2007 Apr - Who cited this? | PubMed ID: 17334980 | Fulltext

Interferon-beta1b in multiple sclerosis.

+ cite this

+ View Abstract

Buttmann M and Rieckmann P

Expert review of neurotherapeutics 7(3):227-39, 2007 Mar - Who cited this? | PubMed ID: 17341170 | Fulltext

Palliative care in patients with severe multiple sclerosis: two case reports and a survey among German MS neurologists.

+ cite this

+ View Abstract

Kümpfel T, Hoffmann LA, Pöllmann W, Rieckmann P, Zettl UK, Kühnbach R, Borasio GD, and Voltz R

Palliative medicine 21(2):109-14, 2007 Mar - Who cited this? | PubMed ID: 17344259 | Fulltext

Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma.

+ cite this

+ View Abstract

Hau P, Koch D, Hundsberger T, Marg E, Bauer B, Rudolph R, Rauch M, Brenner A, Rieckmann P, Schuth J, Jauch T, Koch H, and Bogdahn U

Neurology 68(9):688-90, 2007 Feb 27 - Who cited this? | PubMed ID: 17325277 | Fulltext

Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells.

+ cite this

+ View Abstract

Buttmann M, Berberich-Siebelt F, Serfling E, and Rieckmann P

Journal of vascular research 44(1):51-60, 2007 - Who cited this? | PubMed ID: 17167270 | Fulltext

[Escalating immunomodulatory therapy of multiple sclerosis. Update (September 2006)].

+ cite this

+ View Abstract

Multiple Sklerose Therapie Konsensus Gruppe (MSTKG) and Rieckmann P

Der Nervenarzt 77(12):1506-18, 2006 Dec - Who cited this? | PubMed ID: 17136556 | Fulltext

Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls.

+ cite this

+ View Abstract

Gronen F, Ruprecht K, Weissbrich B, Klinker E, Kroner A, Hofstetter HH, and Rieckmann P

Journal of neuroimmunology 180(1-2):185-92, 2006 Nov - Who cited this? | PubMed ID: 17023054 | Fulltext

Analysis of the C/T(-1) single nucleotide polymorphism in the CD40 gene in multiple sclerosis.

+ cite this

+ View Abstract

Buck D, Kroner A, Rieckmann P, Mäurer M, and Wiendl H

Tissue antigens 68(4):335-8, 2006 Oct - Who cited this? | PubMed ID: 17026470 | Fulltext

Socio-economic aspects of neuroimmunological diseases.

+ cite this

+ View Abstract

Rieckmann P

Journal of neurology 253 Suppl 5:V87-90, 2006 Sep - Who cited this? | PubMed ID: 16998761 | Fulltext

Regulation of human endogenous retrovirus W protein expression by herpes simplex virus type 1: implications for multiple sclerosis.

+ cite this

+ View Abstract

Ruprecht K, Obojes K, Wengel V, Gronen F, Kim KS, Perron H, Schneider-Schaulies J, and Rieckmann P

Journal of neurovirology 12(1):65, 2006 Feb - Who cited this? | PubMed ID: 16595376 | Fulltext

Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis.

+ cite this

+ View Abstract

Kallmann BA, Fackelmann S, Toyka KV, Rieckmann P, and Reiners K

Multiple sclerosis (Houndmills, Basingstoke, England) 12(1):58-65, 2006 Feb - Who cited this? | PubMed ID: 16459720 | Fulltext

["Fatigue" in multiple sclerosis. Development and and validation of the "Würzburger Fatigue Inventory for MS"].

+ cite this

+ View Abstract

Flachenecker P, Müller G, König H, Meissner H, Toyka KV, and Rieckmann P

Der Nervenarzt 77(2):165-6, 168-70, 172-4, 2006 Feb - Who cited this? | PubMed ID: 16160812 | Fulltext

Isolation and culture of microvascular endothelial cells from gliomas of different WHO grades.

+ cite this

+ View Abstract

Miebach S, Grau S, Hummel V, Rieckmann P, Tonn JC, and Goldbrunner RH

Journal of neuro-oncology 76(1):39-48, 2006 Jan - Who cited this? | PubMed ID: 16155723 | Fulltext

Symptomatic treatment of multiple sclerosis. Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society.

+ cite this

+ View Abstract

Henze T, Rieckmann P, Toyka KV, and Multiple Sclerosis Therapy Consensus Group of the German Multiple Sclerosis Society

European neurology 56(2):78-105, 2006 - Who cited this? | PubMed ID: 16966832 | Fulltext

Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).

+ cite this

+ View Abstract

Vordermark D, Ruprecht K, Rieckmann P, Roggendorf W, Vince GH, Warmuth-Metz M, Kölbl O, and Flentje M

BMC cancer 6:247, 2006 - Who cited this? | PubMed ID: 17049083 | Fulltext

EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses.

+ cite this

+ View Abstract

Sellebjerg F, Barnes D, Filippini G, Midgard R, Montalban X, Rieckmann P, Selmaj K, Visser LH, Sørensen PS, and EFNS Task Force on Treatment of Multiple Sclerosis Relapses

European journal of neurology : the official journal of the European Federation of Neurological Societies 12(12):939-46, 2005 Dec - Who cited this? | PubMed ID: 16324087 | Fulltext

Subcutaneous interferon-beta injections in patients with multiple sclerosis initiate inflammatory skin reactions by local chemokine induction.

+ cite this

+ View Abstract

Buttmann M, Goebeler M, Toksoy A, Schmid S, Graf W, Berberich-Siebelt F, and Rieckmann P

Journal of neuroimmunology 168(1-2):175-82, 2005 Nov - Who cited this? | PubMed ID: 16126281 | Fulltext

Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclerosis.

+ cite this

+ View Abstract

Vogler S, Goedde R, Miterski B, Gold R, Kroner A, Koczan D, Zettl UK, Rieckmann P, Epplen JT, and Ibrahim SM

Journal of molecular medicine (Berlin, Germany) 83(10):806-11, 2005 Oct - Who cited this? | PubMed ID: 16021520 | Fulltext

Ultrasound derived imaging and quantification of cell adhesion molecules in experimental autoimmune encephalomyelitis (EAE) by Sensitive Particle Acoustic Quantification (SPAQ).

+ cite this

+ View Abstract

Reinhardt M, Hauff P, Linker RA, Briel A, Gold R, Rieckmann P, Becker G, Toyka KV, Mäurer M, and Schirner M

NeuroImage 27(2):267-78, 2005 Aug 15 - Who cited this? | PubMed ID: 15905104 | Fulltext

Impact of the Asp299Gly polymorphism in the toll-like receptor 4 (tlr-4) gene on disease course of multiple sclerosis.

+ cite this

+ View Abstract

Kroner A, Vogel F, Kolb-Mäurer A, Kruse N, Toyka KV, Hemmer B, Rieckmann P, and Mäurer M

Journal of neuroimmunology 165(1-2):161-5, 2005 Aug - Who cited this? | PubMed ID: 15932772 | Fulltext

The long-term safety and tolerability of high-dose interferon beta-1a in relapsing-remitting multiple sclerosis: 4-year data from the PRISMS study.

+ cite this

+ View Abstract

Gold R, Rieckmann P, Chang P, Abdalla J, and PRISMS Study Group

European journal of neurology : the official journal of the European Federation of Neurological Societies 12(8):649-56, 2005 Aug - Who cited this? | PubMed ID: 16053475 | Fulltext

[MS registry in Germany--design and first results of the pilot phase].

+ cite this

+ View Abstract

Flachenecker P, Zettl UK, Götze U, Haas J, Schimrigk S, Elias W, Pette M, Eulitz M, Hennig M, Bertram J, Hollweck R, Neiss A, Daumer M, Pitschnau-Michel D, and Rieckmann P

Der Nervenarzt 76(8):967-75, 2005 Aug - Who cited this? | PubMed ID: 15806419 | Fulltext

Neurodegeneration and clinical relevance for early treatment in multiple sclerosis.

+ cite this

+ View Abstract

Rieckmann P

International MS journal / MS Forum 12(2):42-51, 2005 Aug - Who cited this? | PubMed ID: 16417814 | Fulltext

A PD-1 polymorphism is associated with disease progression in multiple sclerosis.

+ cite this

+ View Abstract

Kroner A, Mehling M, Hemmer B, Rieckmann P, Toyka KV, Mäurer M, and Wiendl H

Annals of neurology 58(1):50-7, 2005 Jul - Who cited this? | PubMed ID: 15912506 | Fulltext

Multiple sclerosis therapy: new strategies.

+ cite this

Rieckmann P

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 26 Suppl 1:S20, 2005 May - Who cited this? | PubMed ID: 15883682 | Fulltext

Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of interferon beta-1b in patients with secondary progressive multiple sclerosis.

+ cite this

+ View Abstract

Rieckmann P, Kruse N, Nagelkerken L, Beckmann K, Miller D, Polman C, Dahlke F, Toyka KV, Hartung HP, and Stürzebecher S

Journal of neurology 252(5):526-33, 2005 May - Who cited this? | PubMed ID: 15895275 | Fulltext

Soluble Telencephalin in the serum of children after febrile seizures.

+ cite this

Borusiak P, Gerner P, Brandt C, Kilgannon P, and Rieckmann P

Journal of neurology 252(4):493-4, 2005 Apr - Who cited this? | PubMed ID: 15726263 | Fulltext

Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions.

+ cite this

+ View Abstract

Perron H, Lazarini F, Ruprecht K, Péchoux-Longin C, Seilhean D, Sazdovitch V, Créange A, Battail-Poirot N, Sibaï G, Santoro L, Jolivet M, Darlix JL, Rieckmann P, Arzberger T, Hauw JJ, and Lassmann H

Journal of neurovirology 11(1):23, 2005 Feb - Who cited this? | PubMed ID: 15804956 | Fulltext

Search Google Scholar for Rieckmann P

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!